Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Therefore, 100 units = 1 mL
Monitoring Response Patients or research participants typically notice: Appetite suppression within the first 12 weeks Early satiety and slower gastric emptying by weeks 34 Weight loss trends becoming evident by week 8 Continued improvements in glucose metabolism when paired with semaglutide or tirzepatide Side Effects and Considerations Common side effects include: Nausea Mild gastrointestinal discomfort Constipation Injection site reactions These effects are generally transient and dose-dependent, which is why titration is important
This selectivity means potential hair benefits without the systemic hormonal effects associated with pharmaceutical 5-alpha reductase inhibitors like finasteride
For background reading, see PubMeds index of published peptide research
GHK is intended strictly for in vitro research applications
